Revascularization vs. Medical Therapy in Stable Ischemic Heart Disease

被引：10

作者：

Weiss, Sandra ^{[1
]}

Weintraub, William ^{[1
]}

机构：

[1] Christiana Care Hlth Syst, Newark, DE 19718 USA

来源：

PROGRESS IN CARDIOVASCULAR DISEASES | 2015年 / 58卷 / 03期

关键词：

Stable ischemic heart disease; Optimal medical therapy; Percutaneous coronary intervention; CORONARY-ARTERY-DISEASE; FRACTIONAL FLOW RESERVE; BARE-METAL STENTS; OUTCOMES UTILIZING REVASCULARIZATION; EMISSION COMPUTED-TOMOGRAPHY; INCREMENTAL PROGNOSTIC VALUE; RANDOMIZED CLINICAL-TRIALS; DRUG-ELUTING STENTS; FOLLOW-UP; INCOMPLETE REVASCULARIZATION;

D O I：

10.1016/j.pcad.2015.07.005

中图分类号：

R5 [内科学];

学科分类号：

100201 [内科学];

摘要：

The keynote COURAGE and BART-2D trials changed the way the interventional community selects patients for revascularization. What we now consider appropriate, especially for percutaneous coronary intervention, has narrowed significantly in scope compared to previous practice a decade ago. Medical therapy has been shown to be both safe and effective as a primary treatment modality for patients with stable ischemic heart disease on the whole. However, it appears that patients with a heavy ischemic burden may benefit from revascularization, although investigation of this is ongoing. Evidence preliminarily supports this practice with coronary artery bypass grafting, and possibly in specific populations undergoing multivessel intervention with functional assessment of lesion severity during PCI. (C) 2015 Published by Elsevier Inc.

引用

页码：299 / 305

页数：7

共 44 条

[1]

Unrestricted use of drug-eluting stents compared with bare-metal Stents in routine clinical practice - Findings from the national heart, lung, and blood institute dynamic registry [J].

Abbott, J. Dawn ;

Voss, Matthew R. ;

Nakamura, Mamoo ;

Cohen, Howard A. ;

Selzer, Faith ;

Kip, Kevin E. ;

Vlachos, Helen A. ;

Wilensky, Robert L. ;

Williams, David O. .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 50 (21) :2029-2036

[2]

Clinical outcomes based on completeness of revascularisation in patients undergoing percutaneous coronary intervention: a meta-analysis of multivessel coronary artery disease studies [J].

Aggarwal, Vikas ;

Rajpathak, Swapnil ;

Singh, Manjeet ;

Romick, Benjamin ;

Srinivas, Vankeepuram S. .

EUROINTERVENTION, 2012, 7 (09) :1095-1102

[3]

The TIMI risk score for unstable angina/non-ST elevation MI - A method for prognostication and therapeutic decision making [J].

Antman, EM ;

Cohen, M ;

Bernink, PJLM ;

McCabe, CH ;

Horacek, T ;

Papuchis, G ;

Mautner, B ;

Corbalan, R ;

Radley, D ;

Braunwald, E .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 284 (07) :835-842

[4]

A Randomized Trial of Therapies for Type 2 Diabetes and Coronary Artery Disease [J].

Frye R.L. ;

August P. ;

Brooks M.M. ;

Hardison R.M. ;

Kelsey S.F. ;

MacGregor J.M. ;

Orchard T.J. ;

Chaitman B.R. ;

Genuth S.M. ;

Goldberg S.H. ;

Hlatky M.A. ;

Jones T.L.Z. ;

Molitch M.E. ;

Nesto R.W. ;

Sako E.Y. ;

Sobel B.E. .

NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (24) :2503-2515

[5]

Fractional flow reserve to determine the appropriateness of angioplasty in moderate coronary stenosis - A randomized trial [J].

Bech, GJW ;

De Bruyne, S ;

Pijls, NHJ ;

de Muinck, ED ;

Hoorntje, JC ;

Escaned, J ;

Stella, PR ;

Boersma, E ;

Bartunek, J ;

Koolen, JJ ;

Wijns, W .

CIRCULATION, 2001, 103 (24) :2928-2934

[6]

Long-term follow-up after deferral of percutaneous transluminal coronary angioplasty of intermediate stenosis on the basis of coronary pressure measurement [J].

Bech, GJW ;

De Bruyne, B ;

Bonnier, HJRM ;

Bartunek, J ;

Wijns, W ;

Peels, K ;

Heyndrickx, GR ;

Koolen, JJ ;

Pijls, NHJ .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 31 (04) :841-847

[7]

Optimal medical therapy with or without PCI for stable coronary disease [J].

Boden, William E. ;

O'Rourke, Robert A. ;

Teo, Koon K. ;

Hartigan, Pamela M. ;

Maron, David J. ;

Kostuk, William J. ;

Knudtson, Merril ;

Dada, Marcin ;

Casperson, Paul ;

Harris, Crystal L. ;

Chaitman, Bernard R. ;

Shaw, Leslee ;

Gosselin, Gilbert ;

Nawaz, Shah ;

Title, Lawrence M. ;

Gau, Gerald ;

Blaustein, Alvin S. ;

Booth, David C. ;

Bates, Eric R. ;

Spertus, John A. ;

Berman, Daniel S. ;

Mancini, G. B. John ;

Weintraub, William S. ;

Boden, W. ;

O'Rourke, R. ;

Teo, K. ;

Hartigan, P. ;

Weintraub, W. ;

Maron, D. ;

Mancini, J. ;

Weintraub, W. ;

Boden, W. ;

O'Rourke, R. ;

Teo, K. ;

Hartigan, P. ;

Knudtson, M. ;

Maron, D. ;

Bates, E. ;

Blaustein, A. ;

Booth, D. ;

Carere, R. ;

Ellis, S. ;

Gosselin, G. ;

Gau, G. ;

Jacobs, A. ;

King, S., III ;

Kostuk, W. ;

Harris, C. ;

Spertus, J. ;

Peduzzi, P. .

NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (15) :1503-1516

[8]

Percutaneous transluminal coronary angioplasty versus medical treatment for non-acute coronary heart disease: meta-analysis of randomised controlled trials [J].

Bucher, HC ;

Hengstler, P ;

Schindler, C ;

Guyatt, GH .

BMJ-BRITISH MEDICAL JOURNAL, 2000, 321 (7253) :73-77

[9]

Chamberlain DA, 1997, LANCET, V350, P461

[10]

Usefulness of fractional flow reserve for risk stratification of patients with multivessel coronary artery disease and an intermediate stenosis [J].

Chamuleau, SAJ ;

Meuwissen, M ;

Koch, KT ;

van Eck-Smit, BLF ;

Tio, RA ;

Tijssen, JGP ;

Piek, JJ .

AMERICAN JOURNAL OF CARDIOLOGY, 2002, 89 (04) :377-380

← 1 2 3 4 5 →